Literature DB >> 3088568

Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

D A Caugant, L O Frøholm, K Bøvre, E Holten, C E Frasch, L F Mocca, W D Zollinger, R K Selander.   

Abstract

Strains of Neisseria meningitidis responsible for an epidemic of meningococcal disease occurring in Norway since the mid-1970s and for recent increases in the incidence of disease in several other parts of Europe have been identified by multilocus enzyme electrophoresis as members of a distinctive group of 22 closely related clones (the ET-5 complex). Clones of this complex have also colonized South Africa, Chile, Cuba, and Florida, where they have been identified as the causative agents of recent outbreaks of meningococcal disease. There is strong circumstantial evidence that outbreaks of disease occurring in Miami in 1981 and 1982 were caused in large part by bacteria that reached Florida via human immigrants from Cuba.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088568      PMCID: PMC323857          DOI: 10.1073/pnas.83.13.4927

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Serogroup identification of meningococci by a modified antiserum agar method.

Authors:  D E Craven; C E Frasch
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

2.  GENETIC FACTORS DETERMINING COMPETENCE IN TRANSFORMATION OF NEISSERIA MENINGITIDIS. 1. A PERMANENT LOSS OF COMPETENCE.

Authors:  K JYSSUM; S LIE
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  Classification of Neisseria meningitidis group B into distinct serotypes. 3. Application of a new bactericidal-inhibition technique to distribution of serotypes among cases and carriers.

Authors:  C E Frasch; S S Chapman
Journal:  J Infect Dis       Date:  1973-02       Impact factor: 5.226

4.  Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

5.  Five structural classes of major outer membrane proteins in Neisseria meningitidis.

Authors:  C M Tsai; C E Frasch; L F Mocca
Journal:  J Bacteriol       Date:  1981-04       Impact factor: 3.490

6.  Immunochemical characterization of Neisseria meningitidis serotype antigens by immunodiffusion and SDS-polyacrylamide gel electrophoresis immunoperoxidase techniques and the distribution of serotypes among cases and carriers.

Authors:  J T Poolman; C T Hopman; H C Zanen
Journal:  J Gen Microbiol       Date:  1980-02

7.  Sodium dodecyl sulfate-polyacrylamide gel typing system for characterization of Neisseria meningitidis isolates.

Authors:  L F Mocca; C E Frasch
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

8.  Epidemiological patterns of meningococcal disease in Norway 1975-1979.

Authors:  K Bøvre; T W Gedde-Dahl
Journal:  NIPH Ann       Date:  1980-12

9.  Meningococcal disease in Scandinavia.

Authors:  H Peltola; K Jónsdóttir; A Lystad; C J Sievers; I Kallings
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29

10.  Genetic diversity and temporal variation in the E. coli population of a human host.

Authors:  D A Caugant; B R Levin; R K Selander
Journal:  Genetics       Date:  1981-07       Impact factor: 4.562

View more
  111 in total

Review 1.  Bacterial population genetics, evolution and epidemiology.

Authors:  B G Spratt; M C Maiden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

2.  Genetic isolation of meningococci of the electrophoretic type 37 complex.

Authors:  H Claus; J Stoevesandt; M Frosch; U Vogel
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

3.  Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool.

Authors:  Claudio T Sacchi; Anne M Whitney; Michael W Reeves; Leonard W Mayer; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Sterilizing immunity elicited by Neisseria meningitidis carriage shows broader protection than predicted by serum antibody cross-reactivity in CEACAM1-humanized mice.

Authors:  Kay O Johswich; Shannon E McCaw; Lea Strobel; Matthias Frosch; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

5.  Identification of the hypervirulent lineages of Neisseria meningitidis, the ST-8 and ST-11 complexes, by using monoclonal antibodies specific to NmeDI.

Authors:  Heike Claus; Hanne Weinand; Matthias Frosch; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

6.  Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

Authors:  J F Wang; D A Caugant; X Li; X Hu; J T Poolman; B A Crowe; M Achtman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

7.  Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

Authors:  Rachel Urwin; Joanne E Russell; Emily A L Thompson; Edward C Holmes; Ian M Feavers; Martin C J Maiden
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Genetic diversity of penicillin-binding protein 2 genes of penicillin-resistant strains of Neisseria meningitidis revealed by fingerprinting of amplified DNA.

Authors:  Q Y Zhang; D M Jones; J A Sáez Nieto; E Pérez Trallero; B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

9.  High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002.

Authors:  I Smith; D A Caugant; E A Høiby; T Wentzel-Larsen; A Halstensen
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

10.  The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.

Authors:  C M Kahler; L E Martin; G C Shih; M M Rahman; R W Carlson; D S Stephens
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.